Attached files

file filename
8-K - FORM 8-K - RELIV INTERNATIONAL INCv311557_8k.htm

 

EXHIBIT 99

NEWS RELEASE

 

For more information, contact:

 

Steve Albright or: Fred Nielson
Chief Financial Officer   Investor Relations
(636) 733-1305   (636) 733-1314

 

FOR IMMEDIATE DISTRIBUTION

 

Reliv International Reports First-Quarter Financial Results for 2012

 

CHESTERFIELD, Missouri, May 2, 2012 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2012.

 

Reliv reported net sales of $19.7 million for the first quarter of 2012, compared to sales of $21.7 million for the first quarter of 2011. United States sales declined by 14.6 percent for the quarter compared to the same quarter in 2011. International sales for the quarter rose 23.4 percent, led by continued strong growth in Europe.

 

The company reported net income of $532,000, or $0.04 per diluted share, for the first quarter of 2012 compared to net income of $610,000, or $0.05 per diluted share, for the first quarter of 2011. Income from operations for the first quarter of 2012 was $914,000 compared to $1,077,000 in the same quarter of 2011.

 

Net sales in Europe increased by 120 percent to $1.6 million in the first quarter of 2012 compared to $724,000 in the prior-year first quarter. “Europe continues to lead all markets in growth with record-setting sales for Europe in the first quarter of 2012,” said Robert L. Montgomery, chairman, president and chief executive officer of Reliv. “The double-digit growth that started in 2010 has increased as our European distribution network expands. We plan to build on this expansion throughout 2012.”

 

Sales in Asia increased by 7.3 percent in the first quarter of 2012 compared to the prior-year quarter, led by the Philippines. “In the Philippines, sales growth continues to accelerate as well,” he said. “The introduction of single-serving sachets for our most popular products has opened up new selling opportunities for our Philippine Distributors. The launch of LunaRich™ soy powder in the Philippines, an event covered by local mainstream media, has provided further sales momentum.”

 

“In the United States, we continue to implement our plan to use innovation to jump start sales,” Montgomery said. “Leading the way is LunaRich soy powder, the first Reliv-exclusive nutritional ingredient. LunaRich was created through Reliv’s research and development partnership with the

Missouri Plant Science Center. It delivers five to ten times more lunasin than standard soy powders.

 

- MORE -

 

 

 
 

 

Reliv International First-Quarter Financial Results

ADD ONE

 

Lunasin is the peptide scientists have identified as the key to many of soy’s documented health benefits, including cholesterol management, cell health and more.”

 

“Backed by clinical studies, LunaRich has energized our distributor base and given us a new competitive edge in the supplement market,” he said. “Reliv Now® was the first product to contain LunaRich, followed by Reliv Now for Kids and SoySentials® women’s protective supplement. We will add LunaRich to more Reliv formulas in the coming months.”

 

“Reliv’s marketing team is implementing additional online capabilities. We have made more online sales tools available, expanded our social media footprint and developed a new video and multimedia strategy. I believe these additional features will make it easier for distributors to share Reliv and make it easier for new people to get started with Reliv. Enhancements such as these are a part of our commitment to provide an affordable home-based business opportunity, and I believe this will be a factor in returning to sales growth,” Montgomery said.

 

“As we work to build on sales momentum overseas and regain momentum in the United States, we strive to reduce costs and strengthen our balance sheet,” he added. Reliv reported a reduction in selling, general and administrative expenses of $795,000 for the first quarter of 2012 compared to the prior-year period. Reliv had cash and cash equivalents of $6.6 million as of March 31, 2012, a decrease of $584,000 from the balance as of December 31, 2011.

 

As of March 31, 2012, Reliv had 58,530 distributors – a decline of 2.2 percent from March 31, 2011 – of which 5,980 are Master Affiliate level and above. Master Affiliate is the level at which distributors are eligible to earn generation royalties.

 

About Reliv International, Inc.
Reliv International, Inc., based in Chesterfield, Missouri, produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at www.reliv.com, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv’s business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company’s web site, www.reliv.com.

 

--FINANCIAL HIGHLIGHTS FOLLOW –

 

 
 

Reliv International, Inc. and Subsidiaries
ADD TWO
 
Consolidated Balance Sheets

   March 31   December 31 
   2012   2011 
   (Unaudited)     
Assets          
Current Assets:          
 Cash and cash equivalents  $6,590,435   $7,174,213 
 Accounts receivable, less allowances of          
$72,700 in 2012 and $70,300 in 2011   338,384    334,828 
 Accounts due from employees and distributors   32,188    43,191 
 Inventories   4,918,048    4,723,773 
 Other current assets   1,531,541    1,136,376 
           
Total current assets   13,410,596    13,412,381 
           
Other assets   5,868,362    3,584,857 
Net property, plant and equipment   7,284,149    7,421,947 
           
Total Assets  $26,563,107   $24,419,185 
           
Liabilities and Stockholders' Equity          
           
Total current liabilities  $7,640,174   $6,110,449 
Long-term debt, less current maturities   3,421,300    3,566,175 
Other non-current liabilities   286,834    256,710 
Stockholders' equity   15,214,799    14,485,851 
           
Total Liabilities and Stockholders' Equity  $26,563,107   $24,419,185 
           
Consolidated Statements of Operations          
    Three months ended March 31 
    2012    2011 
    (Unaudited)    (Unaudited) 
Product sales  $17,614,840   $19,326,943 
Handling & freight income   2,128,804    2,359,911 
           
Net Sales   19,743,644    21,686,854 
           
Costs and expenses:          
 Cost of products sold   3,900,581    4,220,350 
 Distributor royalties and commissions   7,455,160    8,120,942 
 Selling, general and administrative   7,474,246    8,268,868 
           
Total Costs and Expenses   18,829,987    20,610,160 
           
Income from operations   913,657    1,076,694 
Other income (expense):          
 Interest income   9,314    15,579 
 Interest expense   (30,919)   (36,623)
 Other expense   (22,668)   (68,850)
           
Income before income taxes   869,384    986,800 
Provision for income taxes   337,000    377,000 
           
Net Income  $532,384   $609,800 
           
           
Earnings per common share - Basic  $0.04   $0.05 
 Weighted average shares   12,512,000    12,451,000 
           
Earnings per common share - Diluted  $0.04   $0.05 
 Weighted average shares   12,633,000    12,453,000 
           
Cash dividends declared per common share  $-   $- 

 

*MORE*

 
 

 

Reliv International, Inc. and Subsidiaries
ADD THREE

 

 

 

 

Net sales by Market            
(in thousands)  Three months ended March 31,   Change from 
   2012   2011   prior year 
   Amount   % of Net Sales   Amount   % of Net Sales   Amount   % 
                         
United States   15,770    79.9%   18,466    85.2%   (2,696)   -14.6%
Australia/New Zealand   540    2.7%   618    2.8%   (78)   -12.6%
Canada   550    2.8%   597    2.8%   (47)   -7.9%
Mexico   287    1.4%   348    1.6%   (61)   -17.5%
Europe   1,595    8.1%   724    3.3%   871    120.3%
Asia   1,002    5.1%   934    4.3%   68    7.3%
                               
Consolidated Total   19,744    100.0%   21,687    100.0%   (1,943)   -9.0%

 

                 
        The following table sets forth, as of March 31, 2012 and 2011, the number of our active 
  distributors and Master Affiliates and above.  The total number of active distributors includes Master 
  Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews its 
  distributorship during the prior twelve months.  Master Affiliates and above are distributors that have 
  attained the highest level of discount and are eligible for royalties generated by Master Affiliates and 
  above in their downline organization.  Growth in the number of active distributors and Master Affiliates
  and above is a key factor in continuing the growth of our business.       
               

 

Active Distributors and Master Affiliates and above by Market            
                         
   As of 3/31/2012   As of 3/31/2011   Change in % 
    Active Distributors    Master Affiliates and Above    Active Distributors    Master Affiliates and Above    Active Distributors    Master Affiliates and Above 
                               
United States   42,910    4,550    46,910    5,360    -8.5%   -15.1%
Australia/New Zealand   1,950    120    2,200    140    -11.4%   -14.3%
Canada   1,340    190    1,370    170    -2.2%   11.8%
Mexico   1,640    140    1,630    240    0.6%   -41.7%
Europe   4,900    480    2,570    260    90.7%   84.6%
Asia   5,790    500    5,190    400    11.6%   25.0%
                               
Consolidated Total   58,530    5,980    59,870    6,570    -2.2%   -9.0%
                               

 

** 30 **